This article provides a comprehensive framework for researchers, scientists, and drug development professionals navigating the significant challenge of validating manufacturing processes for Advanced Therapy Medicinal Products (ATMPs) with a limited...
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on addressing common Good Manufacturing Practice (GMP) deficiencies in Advanced Therapy Medicinal Product (ATMP) facilities.
This article provides cell therapy researchers, scientists, and drug development professionals with a comprehensive framework for managing comparability in the European Union.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals addressing the critical challenge of GMP non-compliance in cell therapy manufacturing.
This article provides a comprehensive analysis of the evolving regulatory landscape for point-of-care (POC) and decentralized manufacturing of cell and gene therapies in Europe.
This article provides a detailed guide to the Environmental Risk Assessment (ERA) process for Advanced Therapy Medicinal Products (ATMPs) containing Genetically Modified Organisms (GMOs) in the European Union.
This article provides a comprehensive guide to process validation for cell therapy Advanced Therapy Medicinal Products (ATMPs), addressing the unique challenges faced by researchers and drug development professionals.
This article provides a comprehensive guide to the batch certification process for Advanced Therapy Medicinal Products (ATMPs) in the European Union.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on achieving and maintaining GMP compliance in autologous cell therapy manufacturing.
This guide provides researchers, scientists, and drug development professionals with a comprehensive roadmap for preparing a successful manufacturing authorization application for cell therapies.